CN109771412A - The drug and rat model construction method of reangiostenosis after mitigation balloon injured - Google Patents

The drug and rat model construction method of reangiostenosis after mitigation balloon injured Download PDF

Info

Publication number
CN109771412A
CN109771412A CN201811630908.5A CN201811630908A CN109771412A CN 109771412 A CN109771412 A CN 109771412A CN 201811630908 A CN201811630908 A CN 201811630908A CN 109771412 A CN109771412 A CN 109771412A
Authority
CN
China
Prior art keywords
rip3
mlkl
rip1
drug
balloon injured
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811630908.5A
Other languages
Chinese (zh)
Inventor
黄波
胡培
徐尚福
李利生
吴芹
石京山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zunyi Medical University
Original Assignee
Zunyi Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zunyi Medical University filed Critical Zunyi Medical University
Priority to CN201811630908.5A priority Critical patent/CN109771412A/en
Publication of CN109771412A publication Critical patent/CN109771412A/en
Pending legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The invention belongs to pharmaceutical technology field, the drug and rat model construction method of reangiostenosis after a kind of mitigation balloon injured are disclosed, the drug for mitigating reangiostenosis after balloon injured is naringenin;Rat model construction method include: using 2F sacculus induced male balloon injury of rat carotid arteries model, and the 1st, 3,7 and 14 day observation neointimal hyperplasia pathologic process;Then, rat Nar (25,50,100mg/kg/d) are given by administration by gavage daily, continues 14 days.For the present invention these results indicate that the vascellum endometrial hyperplasia that Nar can inhibit balloon injured to induce by inhibiting release and the oxidative stress of inflammatory factor, this may be related with regulation RIP1-RIP3-MLKL signal path.

Description

The drug and rat model construction method of reangiostenosis after mitigation balloon injured
Technical field
The invention belongs to a kind of drug of reangiostenosis after pharmaceutical technology field more particularly to mitigation balloon injured and greatly Mouse model construction method.
Background technique
Pipe restenosis is proved to be the major defect of percutaneous coronary intervention (pci) (PCI), and PCI is that stenosis is coronal dynamic Primary treatments of arteries and veins vascular lesion, and it is characterized in that neointimal hyperplasia, this be a kind of complexity cell and molecule it is anti- It answers.In recent years, the abnormality proliferation table of endothelial dysfunction and Intima area medium vessels smooth muscle cell (VSMC) has been accepted extensively Type is the trigger point of reangiostenosis.Although the molecule and cell mechanism of reangiostenosis not yet illustrate completely, more and more Evidence show PCI induction inflammatory reaction and oxidative stress play an important role in the pathologic process of endometrial hyperplasia.Largely Research points out that inflammation plays vital adjustment effect in many vascular diseases.It is reported that MAPK and NF- kB activation is adjusted Inflammatory process participates in the endothelial cell damage of TNF-α induction;In addition the vascular inflammation in the dyslipidemia of diet induced may be by The adjusting of oxidative stress and inflammatory cytokine.Various cell factors and inflammatory mediator facilitate the pathogenesis of restenosis, example Such as pro-inflammatory cytokine IL-1 β and TNF-α, play an important role during the occurrence and development of neointimal hyperplasia.In view of These discoveries, the inflammatory reaction and oxidative stress for reducing PCI induction may be to reduce neointimal hyperplasia and reangiostenosis Effective way.
Nowadays, a large amount of evidences show that receptor interacting protein kinases (RIPs) is a kind of crucial tune of procedural gangrenosum acne One of section mechanism, this is a kind of cell death of inflammatory forms.Known RIP1 and RIP3 passes through its RIP homotype interaction motif (RHIM) oligomerization that structural domain mediates forms heterodimer filiform bracket, but the signal based on the bracket in necrosomes Conducted events are not yet fully solved.Mixing pedigree kinase domain sample albumen (MLKL) is functional r IP3 substrate, passes through it Kinases spline structure domain is in conjunction with RIP3 but lacks its own kinase activity.As the typical mechanism of gangrenosum acne apoptosis, report RIP1-RIP3-MLKL signal transduction path is closely related with inflammation, can promote pathological inflammatory process, and and its in cell Function in death is unrelated.Many proinflammatory cytokines such as TNF-α can also cause gangrenosum acne apoptosis.However, not yet studying Effect of the RIP1-RIP3-MLKL signal path after balloon injured in the pathologic process of reangiostenosis.
Naringenin (Naringenin, Nar) is a kind of natural flavanone kind composition, has a variety of pharmacological activities The effects of effect, including antibacterial, anticancer.It is some studies have shown that Nar has the treatment of injury of blood vessel relevant to inflammatory reaction latent Power, but there has been no the researchs about Nar to the potential inhibiting effect of reangiostenosis, especially to the concern of anti-inflammatory effect.
In conclusion problem of the existing technology is:
The pathology mistake of regulation RIP1-RIP3-MLKL signal path reangiostenosis after balloon injured is not yet studied at present Effect in journey.
In the prior art, the effect to naringenin on treatment reangiostenosis, lacks directive significance.
Summary of the invention
In view of the problems of the existing technology, the present invention provides a kind of drugs of reangiostenosis after mitigation balloon injured And rat model construction method.Based on the above, present invention assumes that naringenin (Nar) can mediate regulation RIP1-RIP3-MLKL Signal path, the access play crucial work in adjusting inflammatory cytokine to mitigate in rat carotid artery restenosis after balloon injured With.Therefore, influence of the research Nar to the total intimal hyperplasia of balloon injured posterior neck first.Then, it has studied and inhibits inflammation thin Whether intracellular cytokine release and the relevant this effect of oxidative stress are related with regulation RIP1-RIP3-MLKL signal path.
The invention is realized in this way blood after a kind of RIP1-RIP3-MLKL signal path mitigation balloon injured by regulation The drug of pipe restenosis, the medicine for mitigating reangiostenosis after balloon injured by regulation RIP1-RIP3-MLKL signal path Object is naringenin.
Another object of the present invention is to provide subtracted described in a kind of verifying by regulating and controlling RIP1-RIP3-MLKL signal path The construction method of the rat model of the medicine effect of reangiostenosis, the construction method packet of the rat model after light balloon injured Include following steps:
Step 1, using 2F sacculus induced male balloon injury of rat carotid arteries model;
Step 2, in the pathologic process of the 1st, 3,7 and 14 day observation neointimal hyperplasia;
Step 3 is given rat Nar 25mg/kg/d, 50mg/kg/d and 100mg/kg/d by administration by gavage or is waited daily The CMC-Na of volume continues 14 days;
Step 4 detects experiment.
Further, survey method includes:
Toy ultrasound detection:
Inner film thickness in blood vessel (IMT) is observed and measured using B-Mode, there is the 30MHz peak value petty action for arteria carotis Object ultrasonic probe;The diastasis longitudinal direction image at least continuously beaten three times is obtained, the endometrial morphology to nearly wall and remote wall is clear As it can be seen that using digitlization graduated scale manual measurement.
Further, detection method further comprises: histopathology form inspection:
HE dyeing is used for the inspection of histopathology form.The digitized image being sliced by 53 microscopic analysis of IX, and make It is analyzed with CellSens imaging software with 100x magnifying power and 200x magnifying power: measurement neointima area (NIA), middle film surface Product (MA) and interior elastic plate wrapping area (IELA), and calculate NIA/MA ratio and NIA/IELA ratio.
Further, detection method further comprises: immunohistochemistry:
After tissue is fixed with 4% paraformaldehyde, 5 μm of paraffin sections and PCNA antibody and CD163 antibody are incubated at 4 DEG C Overnight;It will be sliced and secondary antibody incubates 1 hour at 37 DEG C, and haematoxylin redyeing be dyed and used with DAB, then film making observation.
Another object of the present invention is to provide one kind to mitigate sacculus to by regulation RIP1-RIP3-MLKL signal path The detection method of the drug of reangiostenosis includes: ELISA measurement after damage:
Measure the expression of IL-1 β and TNF-α in blood serum sample;All programs are operated according to kit specification.
Further, detection method further comprises: biochemistry detection:
Pass through the level of colorimetric determination oxidative stress correlation factor;SOD activity, MDA and GSH content kit are used for blood Clear biochemistry detection.
Further, detection method further comprises: real-time quantitative RT-qPCR measurement:
Total serum IgE is extracted using trizol kit, then according to using primeScriptTMReverse Transcriptase kit is by 4.0mg RNA reverse transcription is at cDNA;Use iQTMSYBR Green Supermix carries out real-time quantitative RT-qPCR.
Further, PCR amplification condition be recycle within 94 DEG C × 3 minutes and 40 (94 DEG C × 15 seconds, 60 DEG C × 20 seconds and 72 × DEG C 40 seconds).
Advantages of the present invention and good effect are as follows:
The present invention uses 2F sacculus induced male balloon injury of rat carotid arteries model, and observes at the 1st, 3,7 and 14 day The pathologic process of neointimal hyperplasia.Then, rat Nar (25,50 and 100mg/kg/d) is given by administration by gavage or is waited daily The CMC-Na of volume continues 14 days.Ultrasonic examination and histopathological examination show that Nar dose-dependently inhibits sacculus to lead Pipe induction endometrial hyperplasia, Nar can reduce in inner film thickness (IMT), neointimal area (NIA), neointimal area/middle film Area (NIA/MA) and neointimal area/interior elastic plate wrapping area (NIA/IELA).Immunohistochemistry shows that Nar is reduced The protein expression of PCNA.There are highly expressed CD163 in aortic tunica intima, this shows that inflammatory damage occurs after balloon injured Wound.ELISA the result shows that, Nar it is significant reduce interleukin-1 ' beta ' (IL-1 β) and tumor necrosis factor-alpha (TNF-α) excess It generates.By detecting the activity of superoxide dismutase (SOD) and the level of malonaldehyde (MDA) and glutathione (GSH), hair Existing Nar can prevent oxidative stress caused by balloon injured.In addition, RT-qPCR, which proves to handle by Nar, further lowers receptor Interaction protein kinases (RIP1), receptor interacting protein 3 (RIP3) and mixing pedigree kinase domain sample (MLKL) MRNA expression.These results indicate that Nar can inhibit endangium caused by balloon injured by inhibiting the release of inflammatory factor Hyperplasia, this may be related with regulation RIP1-RIP3-MLKL signal path.
Detailed description of the invention
Fig. 1 is that the present invention implements the rat model construction method flow chart provided.
Fig. 2 is the progress figure that the present invention implements rat carotid artery endometrial hyperplasia after the balloon injured provided.(A) (C) petty action The middle inner film thickness (n=3) of arteria carotis communis after object ultrasound detection balloon injured.The position of inner membrance in arrow expression.(B) it and does evil through another person Art group is compared, and the HE of 1,3,7 and 14 day arteria carotis communis dyes (n=6 or 10) after balloon injured, with 100, and × and 200 × are put Big rate shoots photo;(D-F) quantitative analysis of neointimal area (NIA), the ratio calculation of NIA/MA and NIA/MA.
Fig. 3 is that the present invention implements the naringenin provided to the influence diagram of rat freshman endometrial hyperplasia after balloon injured.
Fig. 4 is the present invention naringenin implementing to provide to new intima after balloon injured, PCNA and CD163 immunohistochemistry with And quantization figure;The influence diagram expressed with IL-1 β in serum and TNF-α content.
Fig. 5 is that the naringenin that present invention implementation provides is active to SOD, the influence diagram of MDA and GSH content, and to RIP1- The influence of RIP3-MLKL signal path mrna expression amount.
Specific embodiment
In order to make the objectives, technical solutions, and advantages of the present invention clearer, with reference to embodiments, to the present invention It is further elaborated.It should be appreciated that the specific embodiments described herein are merely illustrative of the present invention, it is not used to Limit the present invention.
The pathology mistake of regulation RIP1-RIP3-MLKL signal path reangiostenosis after balloon injured is not yet studied at present Effect in journey.
Application principle of the invention is described in detail with reference to the accompanying drawing.
As shown in Figure 1, the construction method of rat model provided in an embodiment of the present invention, comprising the following steps:
S101, using 2F sacculus induced male balloon injury of rat carotid arteries model;
S102, in the pathologic process of the 1st, 3,7 and 14 day observation neointimal hyperplasia;
S103 gives rat Nar (25,50 and 100mg/kg/d) or isometric CMC-Na by stomach-filling daily, continues 14 days;
S104 detects experiment.
Application of the invention is further described below with reference to concrete analysis.
In embodiments of the present invention, chemicals and reagent needed for test provided by the invention are as follows:
Naringenin (mw:272.25;Purity: HPLC >=98%) it is purchased from Fei Yu Bioisystech Co., Ltd (Jiangsu Province, China); 2F Forgarty ball conduit is purchased from Edwards Life Sciences (USA).Anti-PCNA and anti-CD163 antibody is purchased from Abcam(USA);RT-qPCR primer is synthesized and is purified by Invitrogen (Chinese Shanghai) customization.Every other reagent is state It is pure to produce analysis.
In embodiments of the present invention, provided by the invention as follows to experiment progress detection method:
(1) toy ultrasound detection
Toy ultrasound detection:
Inner film thickness in blood vessel (IMT) is observed and measured using B-Mode, there is the 30MHz peak value petty action for arteria carotis Object ultrasonic probe;The diastasis longitudinal direction image at least continuously beaten three times is obtained, the endometrial morphology to nearly wall and remote wall is clear As it can be seen that using digitlization graduated scale manual measurement.
(2) histopathology form inspection
HE dyeing is used for the inspection of histopathology form.The digitized image being sliced by 53 microscopic analysis of IX, and make It is analyzed with CellSens imaging software with 100x magnifying power and 200x magnifying power: measurement neointima area (NIA), middle film surface Product (MA) and interior elastic plate wrapping area (IELA), and calculate NIA/MA ratio and NIA/IELA ratio.
(3) immunohistochemistry
After tissue is fixed with 4% paraformaldehyde, 5 μm of paraffin sections and PCNA antibody and CD163 antibody are incubated at 4 DEG C Overnight;It will be sliced and secondary antibody incubates 1 hour at 37 DEG C, and haematoxylin redyeing be dyed and used with DAB, then film making observation.
(4) ELISA is measured
Measure the expression of IL-1 β and TNF-α in blood serum sample.All programs are operated according to kit specification.
(5) biochemistry detection
Pass through the level of colorimetric determination oxidative stress correlation factor.SOD activity, MDA and GSH content kit are used for blood Clear biochemistry detection.
(6) quantitative real-time RT-PCR
Total serum IgE is extracted using trizol kit (Takara), is then used according to the manufacturer's instructions primeScriptTMReverse Transcriptase kit (Takara) is by 4.0mg RNA reverse transcription at cDNA.Use iQTMSYBR Green Supermix (Bio-rad) carries out real-time PCR.PCR cycle condition be 94 DEG C × 3 minutes and 40 recycle (94 DEG C × 15 seconds, 60 DEG C × 40 seconds 20 seconds and 72 × DEG C).By comparing CTMethod calculates data, expresses by reference gene of β-actin.Gene magnification Primer is as shown in table 1.
Application of the invention is further described combined with specific embodiments below.
Embodiment:
1, material and method
1.1, chemicals and reagent
Naringenin (mw:272.25;Purity: HPLC >=98%) it is purchased from Fei Yu Bioisystech Co., Ltd (Jiangsu Province, China); 2F Forgarty ball conduit is purchased from Edwards Life Sciences (USA).Anti-PCNA and anti-CD163 antibody is purchased from Abcam(USA);RT-qPCR primer is synthesized and is purified by Invitrogen (Chinese Shanghai) customization.Every other reagent is state It is pure to produce analysis.
1.2, Animal Model
(n=6-10,280-320g, SPF grades) of male Sprague-dawley rat dynamic purchased from Medical University Of Chongqing's experiment Object center (credit number: SCXK (Chongqing) 2018-0003).It raises in key lab, the Basic pharmacology Ministry of Education, Zunyi Medical College SPF grades of animal houses raise animal with 12 hours periodicity of illuminations, give sufficient diet and drinking-water.During all zooperies meet State's experimental animal guidance operating specification.
Carotid thrombosis model is established according to the following steps: using yellow Jackets (60mg/kg) anesthetized rat, then edge Neck middle position notch exposes left common carotid, and silk thread ligatures distal end external carotid artery, and internal carotid and arteria carotis communis are used Artery clamp folder closes middle clinopodium polycephalum.2F Fogarty conduit is introduced by the arteriotomy in external carotid artery and advances to musculus hyoideus Proximal edge and unclamp arteria carotis communis artery clamp.In order to generate injury of carotid artery, fill sacculus with physiological saline (0.3mL) It is full of, and is drawn it out three times from musculus hyoideus proximal edge to from carotid bifuracation.After damage, external carotid artery is ligatured with 6-0 silk thread. The artery clamp of internal carotid, restoration of blood flow are taken out simultaneously.Muscle and skin are finally sutured, 80,000 IU penicillin of intraperitoneal injection carry out It is anti-infective.
1.3, animal packet and administration
Zoopery is divided into two parts.30 rats are randomly divided into 5 groups (preoperative and 1 day, 3 days, 7 days, 14 days postoperative), Observe the progress of BI.Remaining 60 rat is randomly divided into 6 groups: sham-operation group, sham-operation group+Nar 100mg/kg/d group, model Group and Nar (25,50,100mg/kg/d) group model.Nar is suspended by CMC-Na.Sham-operation and model group give same volume CMC-Na.14 days after BI, rat is put to death.
1.4, toy ultrasound detection
(B-Mode Vevo2100, Fujifilm Visualsonics, Canada) is used to observe and measure inner membrance in blood vessel Thickness (IMT), have for arteria carotis 30MHz peak value toy ultrasonic probe (MS400, FujifilmVisualSonics, average beam frequency range 22-55MHz);It is vertical to obtain the diastasis at least continuously beaten three times To image, the endometrial morphology to nearly wall and remote wall is high-visible, uses digitlization graduated scale manual measurement.
1.5, histopathology form inspection
HE dyeing is used for the inspection of histopathology form.Pass through 53 microscope of IX (Olympus, Japan) analysis slice Image, and analyzed using CellSens (Olympus, Japan) imaging software with 100x magnifying power and 200x magnifying power: it surveys It measures neointima area (NIA), media area (MA) and interior elastic plate wrapping area (IELA), and calculates NIA/MA ratio and NIA/ IELA ratio.
1.6, immunohistochemistry
After tissue is fixed with 4% paraformaldehyde, 5 μm of paraffin sections and PCNA antibody and CD163 antibody are incubated at 4 DEG C Overnight;It will be sliced and secondary antibody incubates 1 hour at 37 DEG C, and haematoxylin redyeing be dyed and used with DAB, then film making observation.
1.7、ELISA
Measure the expression of IL-1 β and TNF-α in blood serum sample.All programs are operated according to kit specification.
1.8, biochemistry detection
Pass through the level of colorimetric determination oxidative stress correlation factor.SOD activity, MDA and GSH content kit are used for blood Clear biochemistry detection.
1.9, real-time quantitative RT-qPCR
Total serum IgE is extracted using trizol kit (Takara), is then used according to the manufacturer's instructions primeScriptTMReverse Transcriptase kit (Takara) is by 4.0mg RNA reverse transcription at cDNA.Use iQTMSYBR Green Supermix (Bio-rad) carries out real-time PCR.PCR cycle condition be 94 DEG C × 3 minutes and 40 recycle (94 DEG C × 15 seconds, 60 DEG C × 40 seconds 20 seconds and 72 × DEG C).By comparing CTMethod calculates data, expresses by reference gene of β-actin.Gene magnification Primer is as shown in table 1.
Table 1
Primer sequences for RT-qPCR
Gene Forward primer(5’-3’) Reverse primer(5’-3’)
RIP 1 AGGAACACAACAAGCAGAGGGA CACAATGGCGAAGCTGTACACAT
RIP3 CTGGTGACAGGATTCATGGAGAA CAGCAGAACATTGGAGGGCTT
MLKL GAGAACAAGAAGCAGGAGCCAG AAGATTCCATCCGCAGAGGG
β-actin CTGAGAGGGAAATCGTGCGT AGGGAGGAAGAGGATGCGG
1.10, statistical analysis
Data are expressed as mean+SD.Use 5.0 editions (GraphPad Software of GraphPad Prism Lnc., SanDiego, CA) statistical software analysis data.Using the multiple comparative test of Tukey, pass through one-way analysis of variance (ANOVA) data are analyzed.P < 0.05 is considered to have statistical significance.
2, application of the invention is further described below with reference to result.
The pathologic process of rat freshman endometrial hyperplasia after 2.1 balloon injureds
Ultrasound detection is carried out to observe the sub- dielectric thickness (Fig. 2A) of CCA after balloon injured.As shown in Figure 2 A, CCA is the 1st It, thickens 3.14%, 27.19%, 69.05% and 99.92% (P < 0.05, Fig. 2 C) for the 3rd day, the 7th day and the 14th day respectively. Vascular tissue's morphological analysis is shown, compared with sham-operation group, intracavitary region obviously narrows, the intimal thickening of balloon injured CCA (Fig. 2 B).Cell imaging system the result shows that, compared with sham-operation group, neointima area, NIA/MA ratio and NIA/IELA The significant increase (P < 0.05, Fig. 2 D, E, F) of ratio.All results show, with the extension of time after balloon injured, CCA's Neointimal hyperplasia obviously increases, especially at the 14th day.
Influence of 2.2 naringenins to rat freshman endometrial hyperplasia after balloon injured
After balloon injury model foundation, Nar (25,50 and 100mg/kg/d) is given by stomach-filling.Pass through ultrasound detection The endometrial hyperplasia situation of arteria carotis communis that (Fig. 3 A) and HE dyeing (Fig. 3 B) are observed show that Nar is significant and reduce in interior film thickness Degree, neointima area, NIA/MA and NIA/IELA ratio, and effect have dose dependent (P < 0.05, Fig. 3 B, 3D, 3E and 3F).In addition, sham-operation group and simple Nar (100mg/kg/d) administration group are without obvious statistical difference, this shows Nar to normal Blood vessel is without negative effect.These results of study show that Nar can inhibit vascellum endometrial hyperplasia.
The influence that 2.3 naringenins express neointima PCNA after balloon injured
In order to observe the potential impact that Nar adjusts VSMCs phenotype in balloon injured artery, contaminated by immunohistochemistry Color detects the protein expression of PCNA, and PCNA is the typical characteristics object of phenotypic differentiation.As shown in Figure 4 A, PCNA positive cell is dyed Brown, the expression of PCNA is negligible in false control group, and that there are a large amount of PCNA in the inner membrance of balloon injured group is positive thin Karyon.However, compared with model control group, the quantity of PCNA positive nucleus in Nar (25,50 and 100mg/kg/d) processing group Significant reduction (Fig. 4 C).
The influence that 2.4 naringenins express neointima CD163 after balloon injured
In order to detect influence of the Nar to macrophage polarization induction inflammatory reaction, immunohistochemistry dye also has been carried out to CD163 Color.CD163 is the typical characteristics object of macrophage.As shown in Figure 4 B, CD163 positive cell dyes brown, in balloon injured group Inner membrance in there are a large amount of CD163 positive nucleus.However, compared with model control group, Nar (25,50 and 100mg/kg/d) The significant reduction (Fig. 4 D) of the quantity of CD163 positive nucleus in processing group.
2.5 naringenins are to new intima after balloon injured, the influence diagram 4E and 4F of -1 β of serum IL and the expression of TNF-α content.
ELISA detection has been carried out to study the influence that Nar generates the inflammatory cytokine that balloon injured induces.Such as Fig. 4 E With shown in 4F, compared with sham-operation group, the horizontal significant raising of model group IL-1 β and TNF-α, and Nar treatment can be with dose-dependant Property to reduce IL-1 β and TNF-α horizontal (P < 0.05).
2.6 naringenins are to SOD activity, the influence of MDA and GSH content.
In order to assess the influence for the oxidative stress that Nar mediates balloon injured, SOD activity and MDA and GSH water are had evaluated It is flat.As shown in Figure 5A, the reduction of the SOD activity as caused by balloon injured (P < 0.05) is reduced by giving Nar.In addition, Nar is inverse The raising (P < 0.05, Fig. 5 B and 5C) of MDA caused by balloon injured and GSH level is turned.
2.7 naringenins are by inhibiting RIP1-RIP3-MLKL signal path to improve inflammatory reaction
Real-time quantitative RT-qPCR detection in (Fig. 5 D, 5E and 5F), balloon injury model group compared with false control group, RIP1, RIP3 and MLKL mRNA expression raises 2.45,8.31 and 3.56 times (P < 0.05).Nar (50 and 100mg/kg/d's) applies (P < 0.05) is expressed with significant recovery RIP1, RIP3 and MLKL mRNA.By 2.5 and 2.6 results it can be found that ELISA result is scorching Property cell factor IL-1 β and TNF-α is horizontal and SOD activity, MDA and GSH result are all consistent with mRNA expression of results, show RIP1-RIP3-MLKL signal path may be the key regulatory factor for inhibiting inflammatory cytokine release and anti-oxidation stress.
The foregoing is merely illustrative of the preferred embodiments of the present invention, is not intended to limit the invention, all in essence of the invention Made any modifications, equivalent replacements, and improvements etc., should all be included in the protection scope of the present invention within mind and principle.

Claims (9)

1. a kind of drug for mitigating reangiostenosis after balloon injured by regulation RIP1-RIP3-MLKL signal path, feature It is, the drug of reangiostenosis is shaddock ped after the RIP1-RIP3-MLKL signal path mitigation balloon injured by regulation Element.
2. described in a kind of verifying claim 1 again by blood vessel after regulation RIP1-RIP3-MLKL signal path mitigation balloon injured The construction method of the rat model of narrow medicine effect, which is characterized in that the construction method of the rat model includes following Step:
Step 1, using 2F sacculus induced male balloon injury of rat carotid arteries model;
Step 2, in the pathologic process of the 1st, 3,7 and 14 day observation neointimal hyperplasia;
Step 3 gives rat Nar 25mg/kg/d, 50mg/kg/d and 100mg/kg/d or isometric by administration by gavage daily CMC-Na, continue 14 days;
Step 4 is detected.
3. the construction method of rat model as claimed in claim 2, which is characterized in that detection method includes:
Toy ultrasound detection:
Inner film thickness IMT in blood vessel is observed and measured using B-Mode, there is the 30MHz peak value toy ultrasound for arteria carotis to visit Head;The diastasis longitudinal direction image at least continuously beaten three times is obtained, the endometrial morphology to nearly wall and remote wall is clear, uses number Change graduated scale manual measurement.
4. the construction method of rat model as claimed in claim 2, which is characterized in that detection method further comprises: tissue Pathology form inspection:
HE dyeing is used for the inspection of histopathology form;The digitized image being sliced by 53 microscopic analysis of IX, and use CellSens imaging software is analyzed with 100x magnifying power and 200x magnifying power: measurement neointima area NIA, media area MA Area IELA is wrapped with interior elastic plate, and calculates NIA/MA ratio and NIA/IELA ratio.
5. the construction method of rat model as claimed in claim 2, which is characterized in that detection method further comprises: immune Groupization:
After tissue is fixed with 4% paraformaldehyde, 5 μm of paraffin sections and PCNA antibody and CD163 antibody were incubated at 4 DEG C Night;It will be sliced and secondary antibody incubates 1 hour at 37 DEG C, and haematoxylin redyeing be dyed and used with DAB, then film making observation.
6. blood vessel is narrow again after mitigating balloon injured by regulation RIP1-RIP3-MLKL signal path described in a kind of pair of claim 1 The detection method of narrow drug, which is characterized in that after mitigating balloon injured by regulation RIP1-RIP3-MLKL signal path The detection method of the drug of reangiostenosis includes: ELISA measurement: the expression of IL-1 β and TNF-α in measurement blood serum sample;Institute There is program to be carried out according to kit specification.
7. narrow again to blood vessel after mitigating balloon injured by regulation RIP1-RIP3-MLKL signal path as claimed in claim 6 The detection method of narrow drug, which is characterized in that after mitigating balloon injured by regulation RIP1-RIP3-MLKL signal path The detection method of the drug of reangiostenosis further comprises: biochemistry detection:
Pass through the level of colorimetric determination oxidative stress correlation factor;SOD activity, MDA and GSH content kit is for serum Biochemistry detection.
8. narrow again to blood vessel after mitigating balloon injured by regulation RIP1-RIP3-MLKL signal path as claimed in claim 6 The detection method of narrow drug, which is characterized in that after mitigating balloon injured by regulation RIP1-RIP3-MLKL signal path The detection method of the drug of reangiostenosis further comprises: real-time quantitative RT-qPCR detection:
Total serum IgE is extracted using trizol kit, then according to using primeScriptTMReverse Transcriptase kit is by 4.0mg RNA Reverse transcription is at cDNA;Use iQTMSYBR Green Supermix carries out real-time quantitative RT-qPCR.
9. narrow again to blood vessel after mitigating balloon injured by regulation RIP1-RIP3-MLKL signal path as claimed in claim 8 The detection method of narrow drug, which is characterized in that PCR amplification condition is to recycle for 94 DEG C × 3 minutes and 40;94 DEG C × 15 seconds, 40 seconds 60 DEG C × 20 seconds and 72 × DEG C.
CN201811630908.5A 2018-12-29 2018-12-29 The drug and rat model construction method of reangiostenosis after mitigation balloon injured Pending CN109771412A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811630908.5A CN109771412A (en) 2018-12-29 2018-12-29 The drug and rat model construction method of reangiostenosis after mitigation balloon injured

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811630908.5A CN109771412A (en) 2018-12-29 2018-12-29 The drug and rat model construction method of reangiostenosis after mitigation balloon injured

Publications (1)

Publication Number Publication Date
CN109771412A true CN109771412A (en) 2019-05-21

Family

ID=66497909

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811630908.5A Pending CN109771412A (en) 2018-12-29 2018-12-29 The drug and rat model construction method of reangiostenosis after mitigation balloon injured

Country Status (1)

Country Link
CN (1) CN109771412A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115531621A (en) * 2022-10-09 2022-12-30 中南大学湘雅二医院 Pharmaceutical composition containing glycyrrhizic acid for coronary drug eluting stent and controlled release system thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1517086A (en) * 2003-01-17 2004-08-04 上海凯曼生物科技有限公司 Medical use of poly hydroxy flavone derivatives
CN101322700A (en) * 2007-06-13 2008-12-17 中国科学院生物物理研究所 Applications of naringenin and naringin as signal pathway inhibitor of transforming growth factor-beta 1
CN102302483A (en) * 2011-07-08 2012-01-04 中国科学院生物物理研究所 Application of flavonoid small molecule medicine in anti-inflammation and associated diseases
CN103340849A (en) * 2013-06-27 2013-10-09 北京大学 Application of naringenin in preparing medicament for preventing and/or treating abdominal aortic aneurysm
CN105596324A (en) * 2015-12-21 2016-05-25 郑金刚 Application of naringenin to preparation of drugs for preventing and/or treating aortic dissection

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1517086A (en) * 2003-01-17 2004-08-04 上海凯曼生物科技有限公司 Medical use of poly hydroxy flavone derivatives
CN101322700A (en) * 2007-06-13 2008-12-17 中国科学院生物物理研究所 Applications of naringenin and naringin as signal pathway inhibitor of transforming growth factor-beta 1
CN102302483A (en) * 2011-07-08 2012-01-04 中国科学院生物物理研究所 Application of flavonoid small molecule medicine in anti-inflammation and associated diseases
CN103340849A (en) * 2013-06-27 2013-10-09 北京大学 Application of naringenin in preparing medicament for preventing and/or treating abdominal aortic aneurysm
CN105596324A (en) * 2015-12-21 2016-05-25 郑金刚 Application of naringenin to preparation of drugs for preventing and/or treating aortic dissection

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHANGWU XU ET AL: "Naringenin Inhibits Angiotensin II-Induced Vascular Smooth Muscle Cells Proliferation and Migration and Decreases Neointimal Hyperplasia in Balloon Injured Rat Carotid Arteries through Suppressing Oxidative Stress", 《BIOL. PHARM. BULL》 *
HUANG BO ET AL: "Naringenin attenuates carotid restenosis in rats after balloon injury via RIP1-RIP3-MLKL signaling pathway", 《首届东方药理论坛暨2018年全国心脑血管药理学术会议、上海市药理学会第十九届学术年会》 *
NARINGENIN INHIBITS NEOINTIMAL HYPERPLASIA FOLLOWING ARTERIAL RE: "Naringenin Inhibits Neointimal Hyperplasia Following Arterial Reconstruction With Interpositional Vein Graft", 《ANNALS OF PLASTIC SURGERY》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115531621A (en) * 2022-10-09 2022-12-30 中南大学湘雅二医院 Pharmaceutical composition containing glycyrrhizic acid for coronary drug eluting stent and controlled release system thereof
CN115531621B (en) * 2022-10-09 2023-06-27 中南大学湘雅二医院 Pharmaceutical composition containing glycyrrhizic acid for coronary artery drug eluting stent and controlled release system thereof

Similar Documents

Publication Publication Date Title
Cybulsky Endoplasmic reticulum stress, the unfolded protein response and autophagy in kidney diseases
Zhang et al. SQSTM1-dependent autophagic degradation of PKM2 inhibits the production of mature IL1B/IL-1β and contributes to LIPUS-mediated anti-inflammatory effect
Tarabra et al. Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes
Kawaguchi et al. Prior starvation mitigates acute doxorubicin cardiotoxicity through restoration of autophagy in affected cardiomyocytes
Liu et al. Genetic or pharmacologic blockade of EGFR inhibits renal fibrosis
Barile et al. The RAGE axis in early diabetic retinopathy
Strupler et al. Second harmonic microscopy to quantify renal interstitial fibrosis and arterial remodeling
Ding et al. Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability
Steinbeck et al. Store-operated calcium entry modulates neuronal network activity in a model of chronic epilepsy
Li et al. Rictor/mTORC2 protects against cisplatin-induced tubular cell death and acute kidney injury
Miller et al. Pronephric tubulogenesis requires Daam1-mediated planar cell polarity signaling
Ozawa et al. A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis xenografts via antiangiogenic activity in severe combined immunodeficiency mice
Lehmann et al. The aryl hydrocarbon receptor ligand ITE inhibits TGFβ1-induced human myofibroblast differentiation
Xu et al. Endocannabinoids exert CB1 receptor-mediated neuroprotective effects in models of neuronal damage induced by HIV-1 Tat protein
Ahmet et al. Long-term low dose dietary resveratrol supplement reduces cardiovascular structural and functional deterioration in chronic heart failure in rats
Prilloff et al. Two faces of calcium activation after optic nerve trauma: life or death of retinal ganglion cells in vivo depends on calcium dynamics
Lu et al. Cold stress accentuates pressure overload-induced cardiac hypertrophy and contractile dysfunction: role of TRPV1/AMPK-mediated autophagy
Wang et al. Quercetin attenuates diabetic neuropathic pain by inhibiting mTOR/p70S6K pathway-mediated changes of synaptic morphology and synaptic protein levels in spinal dorsal horn of db/db mice
Zhang et al. Mitochondrial aldehyde dehydrogenase obliterates endoplasmic reticulum stress-induced cardiac contractile dysfunction via correction of autophagy
Yamaguchi et al. Time-dependent expression of renal vaso-regulatory molecules in LPS-induced endotoxemia in rat
Wu et al. Neuroprotective effect of upregulated sonic Hedgehog in retinal ganglion cells following chronic ocular hypertension
Li et al. Aggravation of acute kidney injury by mPGES-2 down regulation is associated with autophagy inhibition and enhanced apoptosis
Gross et al. Renal damage in the SHR/N-cp type 2 diabetes model: comparison of an angiotensin-converting enzyme inhibitor and endothelin receptor blocker
Yang et al. CD74 knockout attenuates alcohol intake-induced cardiac dysfunction through AMPK-Skp2-mediated regulation of autophagy
Liu et al. Roles of Na+/H+ exchanger type 1 and intracellular pH in angiotensin II-induced reactive oxygen species generation and podocyte apoptosis

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20190521